R&D

GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site

12 days ago   |   By Xconomy

The doors have opened at a GE Healthcare-supported open-access lab for startups at AstraZeneca's former global center for oncology research and development at Alderley Park, the largest bioscience research campus in the UK. The AstraZeneca site in Macclesfield, UK, housed 3,500 staff and was instrumental in developing a number of its cancer drugs including tamoxifen , goserelin , bicalutamide , anastrozole , and gefitinib. But in 2013, the Anglo-Swedish Big Pharma firm exited the site as part of a restructuring that moved its global R&D center and corporate headquarters to Cambridge, UK...
Read more ...

 

AstraZeneca creates $1B Chinese fund, vows to double R&D team

AstraZeneca creates $1B Chinese fund, vows to double R&D team

12 days ago   |   By Fierce Biotech

AstraZeneca is stepping up its commitment to China, detailing plans to double the head count at its Shanghai R&D site and create a $1 billion investment fund. The initiatives build on the rapid growth AstraZeneca has achieved in China in recent years.
Read more ...

 


Search by Tags

   R&D      Cancer      Biosciences      Drugs      Drug      Healthcare      Pharma      Research      Science      Boston blog main      Boston top stories      Boulder      Denver blog main      Denver top stories      Detroit blog main      Detroit top stories      Indiana blog main      Indiana top stories      National      National blog main      National top stories      New York blog main      New York top stories      Raleigh-Durham blog main      Raleigh-Durham top stories      San Diego blog main      San Diego top stories      San Francisco blog main      San Francisco top stories      Seattle blog main      Seattle top stories      Texas blog main      Texas top stories      Wisconsin blog main      Wisconsin top stories      Alderley Park      Anastrozole      AstraZeneca      Bicalutamide      Biotech      Biotech incubator      Conor McKechnie      Danaher      Drug Development      Drug discovery      GE Healthcare      Gefitinib      Goserelin      Jefferson Institute for Bioprocessing      Life Sciences      Manchester Science Parks      National Institute for Bioprocessing      Startups      Tamoxifen      University of Technology Sydney  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Cover Image, Volume 87, Issue 12

Cover Image, Volume 87, Issue 12

Reverse Cover: The cover image is based on the Review Critical assessment of methods of protein structure prediction ‐Round XIII by Andriy Kryshtafovych, Torsten Schwede, Maya... Read more ...

Patient Storytelling: There's an Art to it!

Patient Storytelling: There's an Art to it!

After 30-plus years working in Washington DC, it's clear healthcare decision makers recognize that a patient's story can add value to a discussion when data cannot. While the... Read more ...

Tracking inheritance of human mitochondrial DNA

New insight into how genetic information stored in human mitochondria is passed from one generation to the next could have important implications for genetic counseling of... Read more ...

Researchers clear the path for 'designer' plants

A team of researchers at the University of Georgia has found a way to identify gene regulatory elements that could help produce "designer" plants and lead to improvements in... Read more ...

New method takes analysis of genetic libraries to next level

Uppsala researchers have developed a new method for investigating dynamic processes in large genetic libraries. By using this method to study cell cycle regulation,researchers... Read more ...

Fate Therapeutics: Manager, Quality Assurance

Fate Therapeutics: Fate Therapeutics seeks an experienced, motivated Manager of Quality Assurance to support Fate's internal and external cGMP manufacturing operations. 92121... Read more ...

Discovery of disease- and drug-specific pathways through community...

AbstractMotivationIn light of the massive growth of the scientific literature, text mining is increasingly used to extract biological pathways. Though multiple tools explore... Read more ...

SPDI: Data Model for Variants and Applications at NCBI

AbstractMotivationNormalizing sequence variants on a reference, projecting them across congruent sequences, and aggregating their diverse representations are critical to the... Read more ...

DeepMSA: constructing deep multiple sequence alignment to improve contact...

AbstractMotivationThe success of genome sequencing techniques has resulted in rapid explosion of protein sequences. Collections of multiple homologous sequences can provide... Read more ...

SBML2Modelica: Integrating biochemical models within open-standard...

AbstractMotivationSBML is the most widespread language for the definition of biochemical models. Although dozens of SBML simulators are available, there is a general lack of... Read more ...